cells Archives - Mediarabe

Trump’s “miracle” COVID-19 treatment was developed using cells derived from an aborted fetus: report

October 9, 2020

U.S. President Donald Trump leaves the White House for Walter Reed National Military Medical Center on the South Lawn of the White House on October 2, 2020 in Washington, DC. President Donald Trump and First Lady Melania Trump have both tested positive for coronavirus. Drew Angerer/Getty Images

President Donald Trump has not been shy in his praise for the experimental COVID-19 treatments he received after testing positive last week. In videos posted to Twitter, the president has falsely hailed the therapeutics as “cures” and “miracles coming down from God.”

One of the treatments made available to Trump would have been defeated by his own efforts to thwart the scientific research that made it possible: fetal cell tissue from abortions.

According to Trump’s personal physician, Dr. Sean Conley, the president received a high-dose infusion of monoclonal antibodies last Friday as part of his treatment for COVID-19 infection. Trump was

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

October 9, 2020

| No Comments

| Health News

When the Trump administration suspended federal funding in 2019 for most new scientific research projects involving fetal tissue derived from abortions, officials argued that whatever the scientific benefits, there was a pressing moral imperative to find alternative research methods.

“Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” the Department of Health and Human Services said in a statement released at the time.

Yet the treatment for Covid-19 received by Mr. Trump — a cocktail of monoclonal antibodies he described as a “cure” in a celebratory video posted on Twitter — was developed using human cells derived from a fetus aborted decades ago.

Remdesivir, an antiviral drug that the president received late last week, was also developed with those cell lines. At least two companies racing to create a vaccine against the coronavirus, Moderna and AstraZeneca, are

Covid-19 Live Updates: Treatment That Trump Called a ‘Cure’ Was Tested With Cells Derived From Fetal Tissue

October 8, 2020

| No Comments

| Health

Here’s what you need to know:

President Trump departing the Walter Reed National Military Medical Center on Monday. He has received Regeneron’s cocktail of monoclonal antibodies, among other treatments for Covid-19. — Credit…Doug Mills/The New York Times

The antibody cocktail for Covid-19 that President Trump touted on Wednesday afternoon was developed with cells originally derived from fetal tissue, a practice that his administration has moved to restrict.

In June 2019, the Trump administration suspended federal funding for most new scientific research involving fetal tissue derived from abortions.

“Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” the Department of Health and Human Services said in a statement in 2019, around the time of the ban.

“Intramural research that requires new acquisition of fetal tissue from elective abortions will not be conducted,” the statement added.

Mr. Trump last

Trump’s antibody therapy not made from fetal stem cells

October 8, 2020

| No Comments

| Health Facts

CLOSE

President Trump received mostly the same treatment as anyone would get for COVID-19, except for one experimental drug and the speed of his care.

USA TODAY

The claim: Antibody cocktail Trump received is made from fetal stem cells

Since President Donald Trump’s COVID-19 diagnosis and hospitalization, health care professionals have voiced concerns regarding his broad medical regimen, which include steroid dexamethasone and Gilead’s remdesivir. One treatment in particular, an experimental antibody drug from Regeneron Pharmaceuticals, is drawing criticism on social media.

“So it turns out the monoclonal antibodies Trump is on are from fetal stem cells. So Trump is being treated/saved with dead babies,” reads a Twitter post shared on the Facebook group Dogs for Democracy.

The tweet goes on to call out Republicans, Supreme Court nominee Judge Amy Coney Barrett, and anti-abortion activists.

A follow-up tweet containing a link to Regeneron’s official position statement on stem cell research

Scientists observe cells moving through small channels

October 6, 2020

| No Comments

| Health Article

Oct. 6 (UPI) — Newly captured video of cells moving through narrow channels promises to help scientists better understand the mechanics of cell migration.

The observations, described Tuesday in the journal Biophysical Journal, could offer insights into how cancer metastasizes, or spreads from one area of the body to another.

“Our results describe how cells can migrate and deform through confined spaces, providing potentially new ways to envision cell motility in small blood capillaries in vivo,” senior study author Daniel Riveline, researcher at the University of Strasbourg in France, said in a news release.

Until now, cell motility has mostly been studied on 2D surfaces, but in the body, migrating cells travel through 3D environs. Most often, cells move through blood vessels. For the study, researchers developed vessel-like, micro-fabricated channels.

Some channels were open, confined by just three walls, while others were closer, confined by four walls. Researchers micro-fabricated both

Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conferences Foundation Online Event

October 1, 2020

| No Comments

| Health News

On Wednesday, September 30, 2020, Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading Israeli regenerative medicine company developing a platform of novel biological products, and the Abu Dhabi Stem Cells Center (ADSCC) unveiled their first joint projects in a presentation at the Malta Conferences Foundation (MCF), a global conference supported by kENUP Foundation, a promoter of research-based innovation with public and societal benefit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005476/en/

Malta Conferences address shared desire to improve quality of life and political stability in Middle East through scientific collaboration (Graphic: Business Wire)

Pluristem and ADSCC presented new projects, part of the recently signed Memorandum of Understanding aimed at harnessing the power of regenerative medicine.

The first joint project brings together the expertise of Pluristem and ADSCC to advance a potential COVID-19 treatment. The project will involve the first-time administration of Pluristem’s PLX cells via a nebulizer, a

Elderly hit so hard by COVID-19 because of lower levels of certain immune cells

October 1, 2020

| No Comments

| Health Article

Elderly people who get COVID-19 have lower levels of important immune cells, which may explain why they are more likely than younger patients to have severe symptoms or die, new research suggests.

For the study, the researchers analyzed blood samples from 30 people with mild COVID-19, ranging in age from the mid-20s to late-90s. Compared with healthy people, all of the COVID-19 patients had lower numbers of T cells — which target virus-infected cells — in their blood.

But COVID-19 patients over 80 years of age had fewer T cells than those who were younger, and so-called “killer” T cells in older patients produced lower amounts of cytotoxic molecules that find and kill infected cells, the investigators found.

This age-related difference in immune response may partially explain why older COVID-19 patients have more severe illness, according to the authors of the study published this month in the journal mBio.

“Elderly

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31